NASDAQ : RZLT
Rezolute, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.95 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 414.34M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 29.06M | 29.06M | 18.86M | 15.16M | 12.63M | 9.65M |
| Research & Development | 52.41M | 52.41M | 61.04M | 55.26M | 43.36M | 32.20M |
| Operating Expenses | 81.47M | 81.47M | 79.89M | 70.42M | 55.99M | 41.84M |
| Operating Income | -81.47M | -81.47M | -79.89M | -70.42M | -55.99M | -41.84M |
| Interest Expense | -1.81M | |||||
| Interest & Investment Income | 5.38M | 5.38M | 5.48M | 4.87M | 4.21M | 80.00K |
| Other Non Operating Income (Expenses) | -2.91M | -5.00K | 4.05M | |||
| EBT Excluding Unusual Items | -76.09M | -76.09M | -74.41M | -68.46M | -51.79M | -39.52M |
| Merger & Restructuring Charges | -1.50M | -1.50M | ||||
| Other Unusual Items | -1.54M | |||||
| Pretax Income | -77.59M | -77.59M | -74.41M | -68.46M | -51.79M | -41.06M |
| Net Income | -77.59M | -77.59M | -74.41M | -68.46M | -51.79M | -41.06M |
| Net Income to Common | -77.59M | -77.59M | -74.41M | -68.46M | -51.79M | -41.06M |
| Shares Outstanding (Basic) | 103.91M | 103.91M | 76.00M | 51.47M | 51.19M | 18.20M |
| Shares Outstanding (Diluted) | 103.91M | 103.91M | 76.00M | 51.47M | 51.19M | 19.49M |
| EPS (Basic) | -0.75 | -0.75 | -0.98 | -1.33 | -1.01 | -2.26 |
| EPS (Diluted) | -0.75 | -0.75 | -0.98 | -1.33 | -1.01 | -2.32 |
| Free Cash Flow | -64.64M | -64.64M | -69.08M | -57.37M | -44.63M | -39.62M |
| Free Cash Flow Per Share | -0.62 | -0.62 | -0.91 | -1.11 | -0.87 | -2.03 |
| EBITDA | -81.44M | -81.44M | -79.86M | -70.39M | -55.96M | -41.83M |
| D&A For EBITDA | 31.00K | 31.00K | 31.00K | 36.00K | 30.00K | 13.00K |
| EBIT | -81.47M | -81.47M | -79.89M | -70.42M | -55.99M | -41.84M |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 10.62M | 10.62M | 94.11M | 70.40M | 16.04M | 150.41M |
| Short-Term Investments | 97.19M | 97.19M | 73.75M | 56.48M | 85.86M | |
| Cash & Short-Term Investments | 107.80M | 107.80M | 167.86M | 126.87M | 101.90M | 150.41M |
| Prepaid Expenses | 2.71M | 2.71M | 3.29M | 1.78M | 3.01M | 1.69M |
| Total Current Assets | 110.51M | 110.51M | 171.15M | 128.65M | 104.91M | 152.10M |
| Property, Plant & Equipment | 810.00K | 810.00K | 1.42M | 1.98M | 2.19M | 168.00K |
| Long-Term Investments | 263.00K | 16.47M | ||||
| Other Long-Term Assets | 1.53M | 1.53M | 2.92M | 1.84M | 148.00K | 148.00K |
| Total Assets | 112.85M | 112.85M | 175.49M | 132.74M | 123.72M | 152.42M |
| Accounts Payable | 5.03M | 5.03M | 5.81M | 4.90M | 3.27M | 1.13M |
| Accrued Expenses | 5.73M | 5.73M | 5.47M | 4.14M | 1.39M | 1.22M |
| Current Portion of Leases | 658.00K | 658.00K | 632.00K | 568.00K | 541.00K | 108.00K |
| Total Current Liabilities | 11.42M | 11.42M | 11.91M | 9.61M | 5.20M | 2.46M |
| Long-Term Leases | 276.00K | 276.00K | 983.00K | 1.66M | 1.94M | 80.00K |
| Other Long-Term Liabilities | 468.00K | 468.00K | 468.00K | 468.00K | 412.00K | 407.00K |
| Total Liabilities | 12.16M | 12.16M | 13.36M | 11.73M | 7.55M | 2.95M |
| Common Stock | 96.00K | 96.00K | 87.00K | 53.00K | 37.00K | 34.00K |
| Additional Paid-In Capital | 582.15M | 582.15M | 565.90M | 450.47M | 377.47M | 358.63M |
| Retained Earnings | -481.44M | -481.44M | -403.86M | -329.44M | -260.99M | -209.20M |
| Comprehensive Income & Other | -119.00K | -119.00K | -7.00K | -79.00K | -351.00K | |
| Shareholders' Equity | 100.69M | 100.69M | 162.13M | 121.00M | 116.17M | 149.47M |
| Total Liabilities & Equity | 112.85M | 112.85M | 175.49M | 132.74M | 123.72M | 152.42M |
| Total Debt | 934.00K | 934.00K | 1.61M | 2.23M | 2.48M | 188.00K |
| Net Cash (Debt) | 106.87M | 106.87M | 166.24M | 124.91M | 115.89M | 150.22M |
| Net Cash Per Share | 1.03 | 1.03 | 2.19 | 2.43 | 2.26 | 7.71 |
| Filing Date Shares Outstanding | 96.72M | 96.72M | 90.81M | 55.37M | 36.83M | 38.83M |
| Total Common Shares Outstanding | 96.41M | 96.41M | 87.00M | 53.25M | 36.83M | 33.58M |
| Working Capital | 99.09M | 99.09M | 159.23M | 119.05M | 99.71M | 149.64M |
| Book Value Per Share | 1.04 | 1.04 | 1.86 | 2.27 | 3.15 | 4.45 |
| Tangible Book Value | 100.69M | 100.69M | 162.13M | 121.00M | 116.17M | 149.47M |
| Tangible Book Value Per Share | 1.04 | 1.04 | 1.86 | 2.27 | 3.15 | 4.45 |
| Machinery | 210.00K | 210.00K | 210.00K | 210.00K | 210.00K | 56.00K |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -77.59M | -77.59M | -74.41M | -68.46M | -51.79M | -41.06M |
| Depreciation & Amortization | 31.00K | 31.00K | 31.00K | 36.00K | 30.00K | 13.00K |
| Other Amortization | 424.00K | |||||
| Loss (Gain) From Sale of Investments | -2.45M | -2.45M | -2.39M | -2.84M | -1.37M | |
| Stock-Based Compensation | 14.46M | 14.46M | 7.12M | 7.36M | 7.27M | 3.69M |
| Other Operating Activities | 579.00K | 579.00K | 532.00K | 3.43M | 357.00K | -2.04M |
| Change in Accounts Payable | -748.00K | -748.00K | 1.42M | 1.08M | 2.14M | -11.00K |
| Change in Other Net Operating Assets | 1.08M | 1.08M | -1.37M | 2.02M | -1.11M | -631.00K |
| Operating Cash Flow | -64.64M | -64.64M | -69.08M | -57.37M | -44.48M | -39.62M |
| Capital Expenditures | -153.00K | |||||
| Investment in Securities | -21.10M | -21.10M | -14.54M | 48.70M | -101.31M | |
| Investing Cash Flow | -21.10M | -21.10M | -14.54M | 48.70M | -101.46M | |
| Long-Term Debt Repaid | -16.01M | |||||
| Net Debt Issued (Repaid) | -16.01M | |||||
| Issuance of Common Stock | 2.28M | 2.28M | 87.30M | 49.25M | 12.33M | 168.96M |
| Other Financing Activities | -35.00K | -35.00K | 20.03M | 13.78M | -759.00K | -3.97M |
| Financing Cash Flow | 2.24M | 2.24M | 107.33M | 63.03M | 11.57M | 148.98M |
| Net Cash Flow | -83.49M | -83.49M | 23.71M | 54.36M | -134.37M | 109.36M |
| Free Cash Flow | -64.64M | -64.64M | -69.08M | -57.37M | -44.63M | -39.62M |
| Free Cash Flow Per Share | -0.62 | -0.62 | -0.91 | -1.11 | -0.87 | -2.03 |
| Levered Free Cash Flow | -36.37M | -36.37M | -42.05M | -31.00M | -26.86M | -23.26M |
| Unlevered Free Cash Flow | -36.37M | -36.37M | -42.05M | -31.00M | -26.86M | -22.55M |
| Cash Interest Paid | 1.49M | |||||
| Change in Working Capital | 330.00K | 330.00K | 47.00K | 3.10M | 1.02M | -642.00K |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 407.00M | 543.23M | 387.19M | 228.64M | 72.92M | 108.47M |
| Enterprise Value | 300.13M | 424.07M | 300.56M | 149.42M | -53.98M | 59.56M |
| Last Close Price | 3.88 | 5.20 | 4.46 | 4.30 | 1.98 | 3.23 |
| PB Ratio | 3.72 | 5.39 | 2.39 | 1.89 | 0.63 | 0.73 |
| P/TBV Ratio | 4.04 | 5.39 | 2.39 | 1.89 | 0.63 | 0.73 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 |
| Net Debt / Equity Ratio | -1.06 | -1.06 | -1.02 | -1.03 | -1.00 | -1.00 |
| Net Debt / EBITDA Ratio | 1.31 | 1.31 | 2.08 | 1.77 | 2.07 | 3.59 |
| Net Debt / FCF Ratio | 1.65 | 1.65 | 2.41 | 2.18 | 2.60 | 3.79 |
| Quick Ratio | 9.44 | 9.44 | 14.09 | 13.21 | 19.59 | 61.09 |
| Current Ratio | 9.68 | 9.68 | 14.37 | 13.39 | 20.18 | 61.78 |
| Return on Equity (ROE) | -59.04% | -59.04% | -52.56% | -57.73% | -38.99% | -46.77% |
| Return on Assets (ROA) | -35.32% | -35.32% | -32.40% | -34.33% | -25.35% | -26.82% |
| Return on Capital Employed (ROCE) | -80.30% | -80.30% | -48.80% | -57.20% | -47.20% | -27.90% |
| Earnings Yield | -19.24% | -14.28% | -19.22% | -29.94% | -71.02% | -37.85% |
| FCF Yield | -15.88% | -11.90% | -17.84% | -25.09% | -61.21% | -36.52% |
| Buyback Yield / Dilution | -36.72% | -36.72% | -47.67% | -0.55% | -162.67% | -154.04% |